Advanced Practice Midwife in Robbinsdale, MN Accepting Medicare

1 Advanced Practice Midwife nurses found. Showing 1 - 1

Christina Leigh Krueger, APRN,CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 3300 Oakdale Ave N, Robbinsdale, MN 55422 Phone: 763-520-5200

News Archive

TeamHealth announces acquisition of three affiliated medical groups in the Las Vegas, Nevada

TeamHealth Holdings Inc., a leading physician services organization, announced the acquisition of the operations of three affiliated medical groups: Fremont Emergency Services, Advanced Care Emergency Services and Advanced Care Emergency Specialists, which collectively manage and staff eight hospital emergency departments in the Las Vegas, Nevada, market.

Janssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for treatment of HCV genotype 1 infection

Janssen Research & Development, LLC (Janssen) today announced it has submitted a Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for simeprevir, an NS3/4A protease inhibitor marketed as OLYSIO™ in the United States, in combination with the nucleotide analog NS5B polymerase inhibitor sofosbuvir developed by Gilead Sciences, Inc.

Gallbladder removal surgeries now becomes safer with new imaging procedure

UCLA researchers have discovered an optimal way to image the bile ducts during gallbladder removal surgeries using a tested and safe dye and a real-time near-infrared florescence laparoscopic camera, a finding that will make the procedure much safer for the hundreds of thousands of people who undergo the procedure each year.

MGH researchers find following healthy lifestyle can mitigate genetic risk of heart disease

It is well known that following a healthy lifestyle - not smoking, avoiding excess weight and getting regular exercise - can reduce the risk of heart disease.

Vioxx withdrawal raises many questions concerning drug policy

Daniel H. Solomon, M.D., M.P.H., from Brigham and Women's Hospital, Boston, and Jerry Avorn, M.D., of Harvard University School of Medicine, write in the January 24 issue of Archives of Internal Medicine that the withdrawal of rofecoxib (Vioxx) from the market in September 2004 by its manufacturer, Merck & Co., "raises many questions concerning drug policy, scientific evidence, and treatment alternatives.

Read more Medical News

› Verified 7 days ago